ID PMM1_HUMAN Reviewed; 262 AA. AC Q92871; A8K003; Q92586; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1997, sequence version 2. DT 27-MAR-2024, entry version 196. DE RecName: Full=Phosphomannomutase 1 {ECO:0000303|PubMed:9070917}; DE Short=PMM 1 {ECO:0000303|PubMed:9070917}; DE EC=5.4.2.8 {ECO:0000303|PubMed:16540464}; DE AltName: Full=PMMH-22; GN Name=PMM1; Synonyms=PMMH22; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Liver; RX PubMed=9070917; DOI=10.1006/geno.1996.4536; RA Matthijs G., Schollen E., Pirard M., Budarf M.L., van Schaftingen E., RA Cassiman J.-J.; RT "PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is RT localized on chromosome 22q13."; RL Genomics 40:41-47(1997). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=9119384; DOI=10.1006/geno.1996.4487; RA Wada Y., Sakamoto M.; RT "Isolation of the human phosphomannomutase gene (PMM1) and assignment to RT chromosome 22q13."; RL Genomics 39:416-417(1997). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RA Hansen S.H., Frank S.R., Casanova J.E.; RL Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RX PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84; RA Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A., RA Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J., RA Beare D.M., Dunham I.; RT "A genome annotation-driven approach to cloning the human ORFeome."; RL Genome Biol. 5:R84.1-R84.11(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Skeletal muscle; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=10591208; DOI=10.1038/990031; RA Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M., RA Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C., RA Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E., RA Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C., RA Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G., RA Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V., RA Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., RA Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A., RA Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C., RA Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E., RA Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F., RA Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M., RA Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A., RA Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D., RA Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., RA Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S., RA Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E., RA Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L., RA Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L., RA Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N., RA Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A., RA Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L., RA Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P., RA Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P., RA Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q., RA Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J., RA Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J., RA Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D., RA Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T., RA Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., RA Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., RA Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R., RA Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L., RA McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J., RA Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E., RA Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P., RA Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y., RA Wright H.; RT "The DNA sequence of human chromosome 22."; RL Nature 402:489-495(1999). RN [7] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [8] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain, and Pancreas; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [9] RP ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR RP METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RX PubMed=22814378; DOI=10.1073/pnas.1210303109; RA Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., RA Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., RA Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.; RT "N-terminal acetylome analyses and functional insights of the N-terminal RT acetyltransferase NatB."; RL Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012). RN [10] RP X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH MAGNESIUM IONS AND RP MANNOSE 1-PHOSPHATE, FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, COFACTOR, RP SUBUNIT, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=16540464; DOI=10.1074/jbc.m601505200; RA Silvaggi N.R., Zhang C., Lu Z., Dai J., Dunaway-Mariano D., Allen K.N.; RT "The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal RT the structural basis of congenital disorder of glycosylation type 1a."; RL J. Biol. Chem. 281:14918-14926(2006). RN [11] RP X-RAY CRYSTALLOGRAPHY (1.92 ANGSTROMS) IN COMPLEX WITH MAGNESIUM IONS AND RP INOSINE MONOPHOSPHATE. RX PubMed=29695157; DOI=10.1021/acs.biochem.8b00223; RA Ji T., Zhang C., Zheng L., Dunaway-Mariano D., Allen K.N.; RT "Structural basis of the molecular switch between phosphatase and mutase RT functions of human phosphomannomutase 1 under ischemic conditions."; RL Biochemistry 57:3480-3492(2018). CC -!- FUNCTION: Involved in the synthesis of the GDP-mannose and dolichol- CC phosphate-mannose required for a number of critical mannosyl transfer CC reactions. In addition, may be responsible for the degradation of CC glucose-1,6-bisphosphate in ischemic brain. CC {ECO:0000269|PubMed:16540464}. CC -!- CATALYTIC ACTIVITY: CC Reaction=alpha-D-mannose 1-phosphate = D-mannose 6-phosphate; CC Xref=Rhea:RHEA:11140, ChEBI:CHEBI:58409, ChEBI:CHEBI:58735; CC EC=5.4.2.8; Evidence={ECO:0000269|PubMed:16540464}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:16540464}; CC -!- ACTIVITY REGULATION: IMP, a metabolite whose concentration is elevated CC in anoxia, inhibits phosphomannomutase and phosphoglucomutase CC activities and strongly enhances glucose-1,6-bisphosphatase activity. CC {ECO:0000250|UniProtKB:O35621}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=54 uM for alpha-D-mannose 1-phosphate CC {ECO:0000269|PubMed:16540464}; CC KM=7.5 uM for alpha-D-glucose 1-phosphate CC {ECO:0000269|PubMed:16540464}; CC -!- PATHWAY: Nucleotide-sugar biosynthesis; GDP-alpha-D-mannose CC biosynthesis; alpha-D-mannose 1-phosphate from D-fructose 6-phosphate: CC step 2/2. CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16540464}. CC -!- INTERACTION: CC Q92871; P20340: RAB6A; NbExp=4; IntAct=EBI-746784, EBI-1052826; CC Q92871; P20340-2: RAB6A; NbExp=3; IntAct=EBI-746784, EBI-8840191; CC Q92871; Q9NRW1: RAB6B; NbExp=5; IntAct=EBI-746784, EBI-1760079; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:O35621}. CC -!- TISSUE SPECIFICITY: Strong expression in liver, heart, brain, and CC pancreas; lower expression in skeletal muscle. CC -!- SIMILARITY: Belongs to the eukaryotic PMM family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U62526; AAC51117.1; -; mRNA. DR EMBL; D87810; BAA13460.1; -; mRNA. DR EMBL; U86070; AAC00023.1; -; mRNA. DR EMBL; CR456544; CAG30430.1; -; mRNA. DR EMBL; AK289368; BAF82057.1; -; mRNA. DR EMBL; AK316580; BAG38168.1; -; mRNA. DR EMBL; AL023553; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471095; EAW60443.1; -; Genomic_DNA. DR EMBL; BC010855; AAH10855.1; -; mRNA. DR EMBL; BC016818; AAH16818.1; -; mRNA. DR CCDS; CCDS14020.1; -. DR RefSeq; NP_002667.2; NM_002676.2. DR PDB; 2FUC; X-ray; 2.10 A; A=1-262. DR PDB; 2FUE; X-ray; 1.75 A; A=1-262. DR PDB; 6CFR; X-ray; 2.07 A; A=1-262. DR PDB; 6CFS; X-ray; 2.07 A; A=1-262. DR PDB; 6CFT; X-ray; 2.43 A; A=1-262. DR PDB; 6CFU; X-ray; 2.24 A; A=1-262. DR PDB; 6CFV; X-ray; 1.92 A; A=1-262. DR PDBsum; 2FUC; -. DR PDBsum; 2FUE; -. DR PDBsum; 6CFR; -. DR PDBsum; 6CFS; -. DR PDBsum; 6CFT; -. DR PDBsum; 6CFU; -. DR PDBsum; 6CFV; -. DR AlphaFoldDB; Q92871; -. DR SMR; Q92871; -. DR BioGRID; 111385; 20. DR ComplexPortal; CPX-2131; alpha-D-mannose 1,6-phosphomutase. DR IntAct; Q92871; 14. DR MINT; Q92871; -. DR STRING; 9606.ENSP00000216259; -. DR iPTMnet; Q92871; -. DR PhosphoSitePlus; Q92871; -. DR BioMuta; PMM1; -. DR DMDM; 2499519; -. DR EPD; Q92871; -. DR jPOST; Q92871; -. DR MassIVE; Q92871; -. DR MaxQB; Q92871; -. DR PaxDb; 9606-ENSP00000216259; -. DR PeptideAtlas; Q92871; -. DR ProteomicsDB; 75557; -. DR Pumba; Q92871; -. DR Antibodypedia; 26980; 115 antibodies from 21 providers. DR DNASU; 5372; -. DR Ensembl; ENST00000216259.8; ENSP00000216259.7; ENSG00000100417.12. DR GeneID; 5372; -. DR KEGG; hsa:5372; -. DR MANE-Select; ENST00000216259.8; ENSP00000216259.7; NM_002676.3; NP_002667.2. DR UCSC; uc003bal.3; human. DR AGR; HGNC:9114; -. DR CTD; 5372; -. DR DisGeNET; 5372; -. DR GeneCards; PMM1; -. DR HGNC; HGNC:9114; PMM1. DR HPA; ENSG00000100417; Low tissue specificity. DR MIM; 601786; gene. DR neXtProt; NX_Q92871; -. DR OpenTargets; ENSG00000100417; -. DR PharmGKB; PA33440; -. DR VEuPathDB; HostDB:ENSG00000100417; -. DR eggNOG; KOG3189; Eukaryota. DR GeneTree; ENSGT00390000002918; -. DR HOGENOM; CLU_065642_0_1_1; -. DR InParanoid; Q92871; -. DR OMA; FCLHYMA; -. DR OrthoDB; 167037at2759; -. DR PhylomeDB; Q92871; -. DR TreeFam; TF300874; -. DR BRENDA; 5.4.2.8; 2681. DR PathwayCommons; Q92871; -. DR Reactome; R-HSA-446205; Synthesis of GDP-mannose. DR SABIO-RK; Q92871; -. DR SignaLink; Q92871; -. DR UniPathway; UPA00126; UER00424. DR BioGRID-ORCS; 5372; 10 hits in 1170 CRISPR screens. DR ChiTaRS; PMM1; human. DR EvolutionaryTrace; Q92871; -. DR GeneWiki; PMM1; -. DR GenomeRNAi; 5372; -. DR Pharos; Q92871; Tbio. DR PRO; PR:Q92871; -. DR Proteomes; UP000005640; Chromosome 22. DR RNAct; Q92871; Protein. DR Bgee; ENSG00000100417; Expressed in lower esophagus mucosa and 187 other cell types or tissues. DR ExpressionAtlas; Q92871; baseline and differential. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0043025; C:neuronal cell body; IEA:Ensembl. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0004615; F:phosphomannomutase activity; IDA:UniProtKB. DR GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl. DR GO; GO:0009298; P:GDP-mannose biosynthetic process; TAS:Reactome. DR GO; GO:0006013; P:mannose metabolic process; IDA:UniProtKB. DR GO; GO:0006487; P:protein N-linked glycosylation; IBA:GO_Central. DR CDD; cd02585; HAD_PMM; 1. DR Gene3D; 3.30.1240.20; -; 1. DR Gene3D; 3.40.50.1000; HAD superfamily/HAD-like; 1. DR InterPro; IPR036412; HAD-like_sf. DR InterPro; IPR006379; HAD-SF_hydro_IIB. DR InterPro; IPR023214; HAD_sf. DR InterPro; IPR005002; PMM. DR InterPro; IPR043169; PMM_cap. DR NCBIfam; TIGR01484; HAD-SF-IIB; 1. DR PANTHER; PTHR10466; PHOSPHOMANNOMUTASE; 1. DR PANTHER; PTHR10466:SF1; PHOSPHOMANNOMUTASE 1; 1. DR Pfam; PF03332; PMM; 1. DR SFLD; SFLDF00445; alpha-phosphomannomutase; 1. DR SFLD; SFLDS00003; Haloacid_Dehalogenase; 1. DR SUPFAM; SSF56784; HAD-like; 1. DR Genevisible; Q92871; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cytoplasm; Isomerase; Magnesium; Metal-binding; KW Phosphoprotein; Reference proteome. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0007744|PubMed:22814378" FT CHAIN 2..262 FT /note="Phosphomannomutase 1" FT /id="PRO_0000199692" FT ACT_SITE 19 FT /note="Nucleophile" FT /evidence="ECO:0000269|PubMed:16540464" FT ACT_SITE 21 FT /note="Proton donor/acceptor" FT /evidence="ECO:0000269|PubMed:16540464" FT BINDING 19 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:16540464, FT ECO:0007744|PDB:2FUC, ECO:0007744|PDB:2FUE" FT BINDING 21 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:16540464, FT ECO:0007744|PDB:2FUC, ECO:0007744|PDB:2FUE" FT BINDING 28 FT /ligand="alpha-D-mannose 1-phosphate" FT /ligand_id="ChEBI:CHEBI:58409" FT /evidence="ECO:0000269|PubMed:16540464" FT BINDING 132 FT /ligand="alpha-D-mannose 1-phosphate" FT /ligand_id="ChEBI:CHEBI:58409" FT /evidence="ECO:0000269|PubMed:16540464" FT BINDING 143 FT /ligand="alpha-D-mannose 1-phosphate" FT /ligand_id="ChEBI:CHEBI:58409" FT /evidence="ECO:0000269|PubMed:16540464" FT BINDING 150 FT /ligand="alpha-D-mannose 1-phosphate" FT /ligand_id="ChEBI:CHEBI:58409" FT /evidence="ECO:0000269|PubMed:16540464" FT BINDING 186 FT /ligand="alpha-D-mannose 1-phosphate" FT /ligand_id="ChEBI:CHEBI:58409" FT /evidence="ECO:0000269|PubMed:16540464" FT BINDING 188 FT /ligand="alpha-D-mannose 1-phosphate" FT /ligand_id="ChEBI:CHEBI:58409" FT /evidence="ECO:0000269|PubMed:16540464" FT BINDING 190 FT /ligand="alpha-D-mannose 1-phosphate" FT /ligand_id="ChEBI:CHEBI:58409" FT /evidence="ECO:0000269|PubMed:16540464" FT BINDING 218 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="1" FT /evidence="ECO:0000269|PubMed:16540464, FT ECO:0007744|PDB:2FUC, ECO:0007744|PDB:2FUE" FT BINDING 230 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:16540464, FT ECO:0007744|PDB:2FUC, ECO:0007744|PDB:2FUE" FT BINDING 232 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:16540464, FT ECO:0007744|PDB:2FUC, ECO:0007744|PDB:2FUE" FT BINDING 235 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_label="2" FT /evidence="ECO:0000269|PubMed:16540464, FT ECO:0007744|PDB:2FUC, ECO:0007744|PDB:2FUE" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0007744|PubMed:22814378" FT MOD_RES 242 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:O35621" FT CONFLICT 11 FT /note="K -> R (in Ref. 1; AAC51117)" FT /evidence="ECO:0000305" FT CONFLICT 169 FT /note="A -> D (in Ref. 1; AAC51117)" FT /evidence="ECO:0000305" FT STRAND 14..21 FT /evidence="ECO:0007829|PDB:2FUE" FT TURN 22..24 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 33..42 FT /evidence="ECO:0007829|PDB:2FUE" FT TURN 43..45 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 46..51 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 56..63 FT /evidence="ECO:0007829|PDB:2FUE" FT TURN 66..68 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 69..72 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 74..78 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 79..81 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 83..86 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 89..91 FT /evidence="ECO:0007829|PDB:2FUC" FT HELIX 96..100 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 102..117 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 128..131 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 136..138 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 147..160 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 162..173 FT /evidence="ECO:0007829|PDB:2FUE" FT TURN 174..176 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 179..182 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 185..187 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 189..193 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 198..201 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 202..205 FT /evidence="ECO:0007829|PDB:2FUE" FT TURN 206..209 FT /evidence="ECO:0007829|PDB:2FUC" FT STRAND 211..218 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 227..231 FT /evidence="ECO:0007829|PDB:2FUE" FT STRAND 235..239 FT /evidence="ECO:0007829|PDB:2FUE" FT HELIX 243..254 FT /evidence="ECO:0007829|PDB:2FUE" SQ SEQUENCE 262 AA; 29747 MW; 1FBA7BFC9C3BB0BB CRC64; MAVTAQAARR KERVLCLFDV DGTLTPARQK IDPEVAAFLQ KLRSRVQIGV VGGSDYCKIA EQLGDGDEVI EKFDYVFAEN GTVQYKHGRL LSKQTIQNHL GEELLQDLIN FCLSYMALLR LPKKRGTFIE FRNGMLNISP IGRSCTLEER IEFSELDKKE KIREKFVEAL KTEFAGKGLR FSRGGMISFD VFPEGWDKRY CLDSLDQDSF DTIHFFGNET SPGGNDFEIF ADPRTVGHSV VSPQDTVQRC REIFFPETAH EA //